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Abstract
Background: Myeloid-related protein 8 (MRP8) and MRP14 are S100 family calcium binding
proteins that form a heterodimer known as calprotectin or MRP8/14 that is present in the cytosol
of neutrophils and monocytes. MRP8/14 becomes associated with endothelium at sites of
monocyte and neutrophil adhesion and transmigration and induces a thrombogenic and
inflammatory response by increasing the endothelial transcription of proinflamatory chemokines
and adhesion molecules. The distribution of MRP8/MRP14 among neutrophil granules and plasma
membranes is unclear and was investigated to better understand the role of this molecule in acute
inflammation.
Study design: Three monoclonal antibodies specific for MRP8 and MRP14 were characterized and
used in immunoblotting assays of neutrophil whole cell extracts, and isolated plasma membranes,
primary granules, secondary granules and cytosol.
Results: MRP8 and MRP14 were detected in neutrophil cytosol, plasma membrane, primary
granule and secondary granule fractions. MRP8/14 demonstrated a calcium-dependent adherence
to plasma membranes and primary granules and could be removed by washing with EGTA in a high
ionic strength buffer. In contrast, MRP8/14 was found within the contents of the secondary
granules. Activated neutrophils released secondary granules and MRP8/14.
Conclusion: MRP8/14 is located in neutrophil cytosol and secondary granule fractions and is
loosely associated with plasma membranes. MRP8/14 released with secondary granules by activated
neutrophils likely binds to endothelium and plays an important role in acute inflammation.
Introduction
Calprotectin is a heterodimer of two calcium-binding pro-
teins that belong to the S100 family: myeloid-related pro-
tein 8 (MRP8) and MRP14. MRP8 (10.8 kDa) is also
known as p8, L1 light chain, calgranulin A, and cystic
fibrosis antigen (CFA). MPR14 (13.2 kDa) is also referred
to as p14, L1 heavy chain, and calgranulin B [1-7]. MRP8
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and MRP14 bind both calcium and zinc. Calprotectin is
also known as MRP8/14.
Neutrophils are the major producers of calprotectin, but
monocytes and some macrophages express MRP8/14.
Macrophages found at the sites of acute infection express
MRP8/14, but resident tissue macrophages and those
found at the sites of chronic inflammation do not [7].
MRP8/14 is found in the cytosol of neutrophils and mac-
rophages[8,9]. It is the most abundant protein in neu-
trophil cytosol making up 30% to 60% of all cytosolic
proteins[8], but it is much less abundant in monocytes
and comprises about 1% of all monocyte cytosol protein
[10].
MRP8/14 plays an important role in leukocyte interac-
tions with endothelium. It is not expressed by endothe-
lium, however, examination of tissue sections revealed
that MRP8/14 becomes associated with endothelium at
sites where monocytes and neutrophils pass through the
endothelium [7]. In vitro studies have found that when
activated monocytes come in contact with extracellular
matrix proteins or inflamed endothelium intracellular cal-
cium levels increase, protein kinase C is activated, and
MRP8/14 is released [11,12]. Once MRP8/14 is released it
binds to the endothelium. Two mechanisms of binding
have been proposed. One group has shown that MRP14
binds to endothelial cell heparan sulfate proteogly-
cans[13] and another that MRP8/MRP14 binds to carbox-
ylated N-glycans expressed by activated endothelial cells
[14].
Once associated with the endothelium, MRP8/14 has
important proimflamatory effects. The binding of MRP8/
14 to endothelium induces a thrombogenic and inflam-
matory response by increasing the transcription of proim-
flamatory chemokines and adhesion molecules and by
decreasing the expression of cell junction proteins and
molecules involved in cell monolayer integrity [15].
Elevated levels of MRP8/14 have been found in many sites
of inflammation and in the extracellular fluid of patients
with many types of inflammatory conditions. The concen-
tration of MPR8/14 in the blood is increased in patients
with rheumatoid arthritis, Chron's disease, colorectal can-
cer, cystic fibrosis, multiple scerlosis, and HIV infections
[1,2,4,6,16]. Extracellular MRP8/14 has antimicrobial,
antigrowth and apoptotic effects. It suppresses the growth
of some fungi and bacteria [1,2]. It also suppresses the
proliferation of several different types of cells including:
macrophages, lymphocytes, hematopoietic progentitors,
and tumor cell lines. MRP8/14 can also induce apoptosis
of some tumor cell lines [1,2].
The primary source of MRP8/14 in tissues and body fluids
has been suggested to be the cytosol of dead or lysed neu-
trophils [2]. However, the source of neutrophil MRP8/
MRP14 that becomes associated with endothelium is not
certain. While MRP8/14 is the most abundant neutrophil
cytosol protein, investigations of the distribution of
MRP8/14 among neutrophil granules and plasma mem-
branes have yielded conflicting results. Some studies have
reported that MRP8/14 is present in neutrophil cytosol
and plasma membranes, but the primary or secondary
granules were not analyzed [3,17]. However, another
study did not detect MRP8/14 in either the plasma mem-
branes or granules [10].
This study analyzed the neutrophil subcellular distribu-
tion of MRP8 and MRP14 to better understand changes in
expression of MRP8/14 by activated neutrophils and the
role of neutrophil MRP8/14 in acute inflammation. The
expression of MRP8/14 on neutrophil plasma mem-
branes, primary granules, secondary granules and cytosol
was analyzed.
Materials and methods
Isolation of Neutrophils
Neutrophils were isolated by dextran sedimentation and
centrifugation over Ficoll-Hypaque using a modification
of the method of Boyum [18,19] and suspended in phos-
phate-buffered saline (PBS) or Hank's balanced salt solu-
tion (HBSS; GIBCO, Grand Island, NY).
Production of Monoclonal Antibodies
The monoclonal antibodies (MoAbs) were produced
using BALB/c mice as previously described [20]. MoAbs
AHN-17, AHN-17.1, and 15H9 were produced using
human neutrophils as the immunogen, and AHN-17.1
using human eosinophils obtained from a patient with
hypereosinophilic syndrome.
Characterization of Monoclonal Antibodies
All 3 MoAbs were IgG1. The MoAbs were tested by immu-
nostaining [21] against neutrophil slide preparations, pre-
pared by cytocentrifugation and all three reacted with
neutrophils. AHN-17 and AHN-17.1 were used as ascites
and 15H9 as isolated immunoglobulin.
Immunoblotting of Neutrophil Proteins
Neutrophils (1 × 108 per mL of PBS) were treated with 5
mmol/L diisopropylfluorophosphate (DIFP) (Sigma
Chemical Company, St. Louis, MO) for 10 minutes at 4°C
and were washed twice with PBS. The cells were resus-
pended at a concentration of 5 × 107 cells/mL in a buffer
containing 5 mM Tris (Sigma), 400 mM KCl, 1 mM EDTA
(Sigma), 1% Triton-X-100, and 2 mM (PMSF) (Sigma),
pH 8.2 (Extraction Buffer) [20]. The solution was then fro-
zen, thawed, and centrifuged at 10,000 g, for 10 minutesJournal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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at 4°C. The cell extract was then analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), transferred to nitrocellulose, and immunoblotted
as previously described [22]. SDS-PAGE was performed in
a 13% gel and the cell extracts were analyzed under both
reducing and non-reducing conditions. MoAb 15H9 was
used at a final concentration of 10 µg/mL and the ascites
containing AHN-17 and AHN-17.1 at a dilution of 1:300.
Subcellular Fractionation of Neutrophils
Subcellular fractionation of neutrophils was performed
using a modification of the method described by Borre-
gaard et al [22,23]. Briefly, neutrophils were resuspended
in 10 mL ice cold Relaxation Buffer [100 mM KCI, 3 mM
NaCl, 1 mM adenosine triphosphate (Na)2 (Sigma), 3.5
mM MgCl2, and 10 mM piperazine-N, N-bis (2-ethanesul-
fonic acid) (PIPES) (Sigma), pH 7.3]. This solution was
then equilibriated for 20 minutes at 4°C with nitrogen at
350 PSI with constant slow stirring in a cell disruption
bomb (Parr Instrument, Moline, IL Model no 4639). The
suspension was then collected drop wise into 2.2 mL of
12.5 mM EDTA (Sigma), pH 7.4 in Relaxation Buffer.
Nuclei and unbroken cells were removed by centrifuga-
tion at 500 g for 20 minutes at 4°C. Percoll (Pharmacia
Fine Chemicals, Piscataway, NJ) was adjusted to a density
of 1.120 and 1.050 g/mL with relaxation buffer 10 times
concentrated. The 1.050 density Percol was laid over the
1.120 density Percol, and the supernate was loaded onto
the Percol gradients, which had been precooled at 4°C.
The pelleted membranes and granules were resuspend in
Relaxation Buffer and centrifuged at 100,000 g for 90
minutes at 4°C. The membranes and granules were
washed again with relaxation buffer and analyzed by
immunoblotting. The plasma membrane, primary gran-
ule, secondary granule, and cytosol fractions were ana-
lyzed by immunoblotting with AHN-1.1 (CD15) [20],
AHN-10 (anti-elastase) [24], AHN-9 (anti-lactoferrin)
[21], and AHN-11 (anti-cathepsin G) [21] to confirm that
adequate separation had occurred.
In other studies the plasma membranes, primary, and sec-
ondary granules were centrifuged at 100,000 g for 90 min-
utes at 4°C and resuspended in 1 M NaCl and 10 mM
EGTA (Sigma), pH 7.4 in Relaxation Buffer. The wash was
repeated and then the plasma membranes, primary gran-
ules and secondary granules were disrupted by freeze
thawing twice and sonicating (Microultrasonic Cell Dis-
rupter, model KT40 Kontz) for 1 minute on ice. The mem-
branes and soluble granule contents were separated by
centrifugation at 120,000 g for 90 minutes at 4°C. Protein
concentrations of the fractions were determined by bicin-
choninic acid (BCA) protein assay C (Pierce Chemical
Company, Rockford, IL).
Stimulation of Neutrophils
Neutrophils at a concentration of 107/mL in HBSS were
incubated at 37°C for 15 minutes alone or with phorbol
myristate acetate (PMA) (100 ng/mL) (Sigma) or N-for-
mal-Met-Leu-Phe (FMLP) (10-6M) (Sigma). The solution
was then centrifuged at 500 g for 10 minutes and the
supernatant was analyzed by immunoblotting.
Isolation of Proteins
MoAbs AHN-17 and 15H9 were immobilized on a pro-
tein A column and crosslinked with dimethyl pimelimi-
date according to the manufacturer instructions (lmmuno
Pure IgG Orientation kit (Pierce). Neutrophils or subcel-
lular fractions were suspended at a concentration of 5 ×
107/mL in Extraction Buffer. The solution was then fro-
zen, thawed, and centrifuged at 10,000 g for 10 minutes
at 4°C. The neutrophil extact was mixed 1:1 with 10 mM
Tris, ph 7.5, and applied to the immunoaffinity column.
After the column was washed with 150 mM NaCl, 0.2%
Triton X-100, 10 mM Tris, pH 7.5 to remove unbound
protein. Antigens were eluted with 0.1 M glycine, pH 2.8,
containing 0.2% Triton X-100 and immediately neutral-
ized with 2 M Tris-HCI, pH 7.6.
The 10 kDa and 14 kDa proteins isolated with MoAb
AHN-17 were analyzed by SDS-PAGE and coomassie blue
staining or immunoblotting. The 10 and 14 kDa proteins
isolated with MoAb 15H9 were separated by reverse phase
high pressure liquid chromatography (HPLC) using C-4
column (Vydac, Hesperia, CA) which had been pre-equil-
ibrated with three column volumes of 0.1% trifluoroace-
tic acid. The bound proteins were eluted from the column
by application of 0–60% gradient of acetonitrite over 50
minutes. Aliquots (1 mL) were collected and analyzed by
SDS-PAGE and silver staining or immunoblotting with
MoAb 15H9. The N- terminal amino acid sequence of the
10 and 14 kDa proteins were analyzed using an auto-
mated amino acid sequencer (ABl 470/477, Applied Bio-
system Inc, Foster City, CA).
Tryptic Digestion of the 14 kDa Protein
The isolated 14 kDa protein was dried using vacuum cen-
trifugation. The dried proteins were resuspended in 50 µL
of a solution containing 8 M urea and 0.4 M ammonium
bicarbonate and following the addition of 10 µL 45 mM
dithiothreitol (Sigma) was incubated for 30 minutes at
50°C. After the solution cooled to 20°C, 10 µL of 100
mM iodacetamide (Sigma) was added and the solution
was incubated for 30 minutes in the dark at 20°C. Next,
trypsin (Worthington Biochemical Corp, Freehold, NJ) in
120 µL of water at 1:25 (w/w) ratio of enzyme to protein
(determined by BCA) was added and the solution was
incubated at 37°C for 24 hours. The resulting tryptic frag-
ments were separated by high pressure liquid chromatog-
raphy (HPLC) (C-18 Column, Vydac, Hesperia, CA). TheJournal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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N-terminal amino acid sequence of the tryptic fragments
was analyzed using an automated amino acid sequence
(Applied Biosystems).
Results
Characterization of MoAbs AHN-17, AHN-17.1, and15H9 
as Specific for MRP8 and MRP14
All three MoAbs were tested in an immunoblotting assay
against neutrophils analyzed by SDS-PAGE under non-
reducing conditions. Multiple proteins of various appar-
ent molecular weights were detected by AHN-17, AHN-
17.1, and 15H9 and the pattern of proteins detected was
similar for all three MoAbs (data not shown). AHN-17
and AHN-17.1 did not react by immunoblotting with pro-
teins from extracts analyzed by SDS-PAGE under reducing
conditions, but 15H9 reacted with two proteins of 10 kDa
and 14 kDa (data not shown). These results suggest that
the three antibodies react with same proteins, but the epti-
opes recognized by AHN-17 and AHN-17.1 are confirma-
tion dependent.
To determine if all three MoAbs reacted with the same
proteins, the antigens recognized by AHN-17 were iso-
lated by affinity chromatography with AHN-17 and were
analyzed by immunoblotting with AHN-17, AHN-17.1,
and 15H9. When the purified proteins were analyzed by
SDS-PAGE under non-reducing conditions and coomassie
blue staining, several bands were detected but when ana-
lyzed under reducing conditions only a 10 kDa and 14
kDa protein were detected (data not shown). When the
isolated proteins were analyzed by SDS-PAGE under non-
reducing conditions and immunoblotting, AHN-17 (Fig-
ure 1, lane A), AHN-17.1 (lane B) and 15H9 (lane C)
reacted with several bands and the proteins identified by
all three antibodies were similar. Immunoblotting with
normal mouse serum (NMS) did not detect these proteins
(lane D). These results indicate that all three antibodies
recognized the same proteins.
The 10 and 14 kDa proteins purified by affinity chroma-
tography with MoAb AHN-17 were separated by HPLC,
and the N-terminal amino acid sequence of the 10 kDa
protein was analyzed. A sequence of 29 amino acids was
identified which was identical to that of MRP8 (Figure 2).
The N-terminus of the 14 kDa protein was blocked, how-
ever, the amino acid sequences of two tryptic peptides
were determined and found to be identical to MRP14 at
25 of 27 amino acids (Figure 2).
Subcellular Distribution of MRP8 and MRP14 within 
Neutrophil Granules
Nitrogen cavitation and density gradient separation was
used to isolate neutrophil cytosol, plasma membranes,
primary granules, and secondary granules. The secondary
granule fraction also contains a distinct granule popula-
tion termed tertiary or gelatinase granules [25]. The pro-
teins recognized by AHN-17 were isolated from each of
these fractions by affinity chromatography and analyzed
by SDS-PAGE under reducing and non-reducing condi-
tions. When the proteins were analyzed by SDS-PAGE
under non-reducing conditions, molecules of several elec-
trophoretic mobilities were detected (Figure 3, lanes A-D).
However, only two proteins of 10 and 14 kDa were
detected when the analysis was preformed under reducing
conditions (Figure 3, lanes E-H). These studies show that
MRP8 and MRP14 are located in the neutrophil cytosol,
Immunoblotting of proteins purified by affinity chromatogra- phy using monoclonal antibody AHN-17 Figure 1
Immunoblotting of proteins purified by affinity chromatogra-
phy using monoclonal antibody AHN-17. Neutrophil proteins 
recognized by AHN-17 were isolated by immunoaffinity 
chromatography, analyzed by SDS-PAGE in a 13% gel under 
non-reducing conditions, transferred to nitrocellulose, and 
immunoblotted with AHN-17 (lane A), AHN-17.1 (lane B), 
15H9 (lane C), and normal mouse serum (NMS) (lane D). 
Proteins used as molecular weight standards were: rabbit 
muscle phosphorylase B, 97,000; Bovine serum albumin 
66,000; ovalbumin 45,000; glyceraldehyde 3 phosphate dehy-
drogenase, 36,000; bovine erythrocyte carbonic anhydrase 
30,000; soybean trypsin inhibitor 20,000; and bovine lactalbu-
min 14,000.Journal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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plasma membrane, and secondary granule, and to a lesser
degree primary granule fractions.
To further determine the location of the proteins in the
cellular granules, primary and secondary granules were
washed and disrupted by freeze-thawing and sonication
and the membranes were separated from the granule con-
tents by centrifugation as described in the methods sec-
tion. Equal amounts of protein from the cytosol, plasma
membranes, primary granule membranes, secondary
granule membranes, and the soluble contents of the pri-
mary and secondary granules were analyzed by immuno-
blotting with 15H9 (Figure 4). Both MRP8 and MRP14
were detected by 15H9 in the cytosol (Figure 4, first panel,
lane A) and the soluble portion of the primary and sec-
ondary granules (Figure 4, first panel, lane E and F). MRP8
was also detected on the plasma membrane fractions (Fig-
ure 4, first panel, lane D). The largest quantities of the
MRP8 and MRP14 were present in cytosol and in the sol-
uble portion of the secondary granules. In contrast, NMS
did not react with any proteins of similar electrophoretic
mobility (Figure 4, second panel lanes A through F).
These studies were repeated but the plasma membranes,
primary granules and secondary granules were washed
two additional times with a high ionic strength buffer
Comparison of the N-terminal amino acid sequences of the 10 kDa protein and MRP8 (panel A) and the amino acid sequences  of the two tryptic peptides from the 14 kDa protein with MRP14 (panel B) Figure 2
Comparison of the N-terminal amino acid sequences of the 10 kDa protein and MRP8 (panel A) and the amino acid sequences 
of the two tryptic peptides from the 14 kDa protein with MRP14 (panel B).Journal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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containing EGTA to disrupt loose associations of MRP8
and MRP14 with plasma membranes and granules. After
the primary and secondary granules were disrupted by
freeze thawing and sonication, the plasma membranes,
secondary granules, and soluble contents of the granules
were analyzed by immunoblotting. MRP8 and MRP14
were present only in the soluble portion of the secondary
granules, but not the plasma membranes or primary gran-
ules (data not shown).
The neutrophil plasma membrane, cytosol, and granule
fractions were also immunoblotted with AHN-10 (anti-
elastase), AHN-9 (anti-lactoferrin), AHN-11 (anti-cathep-
sin G), and AHN-1.1 (CD15) to confirm adequate frac-
tionation. As expected, elastase and cathepsin G were
found in the primary granule contents, and lactoferrin in
the secondary granule contents. The CD15 antibody
reacted with plasma membranes and secondary granule
membranes as expected (data not shown).
To examine the ability of neutrophils to release MRP8/14
when activated neutrophils were stimulated with PMA or
FMLP to release secondary granules and tertiary granules,
the cell suspension was centrifuged and the supernatant
was analyzed by immunoblotting with MoAb 15H9. A
small amount of MRP8 and MRP14 was detected in the
supernatant of cell incubated in HBSS, however, the quan-
tities of MRP8 and MRP14 in the supernatant was
increased significantly after stimulation with PMA and
FMLP (data not shown).
Discussion
The expression of MRP8 and MRP14 in neutrophils was
analyzed using MoAbs AHN-17, AHN-17.1, and 15H9.
Antibody specificity was confirmed by amino acid
sequencing; the N-terminal amino acid sequence of the 10
kDa protein recognized by the antibodies was found to be
identical to MRP8. The N-terminus of the 14 kDa protein
recognized by the antibodies was blocked, but amino acid
sequencing of tryptic peptides showed that the protein
was MRP14. MRP8 and MRP14 have a similar structure
and other antibodies have been found to react with both
proteins [8,9]. MRP8 and MRP14 are encoded by two sep-
arate genes located on chromosome 1q12-q21[26].
This study confirmed that MRP8/14 are in neutrophil
cytosol and found that MRP8 and MRP14 are also in the
secondary granule fraction with a much smaller amount
in the primary granule fraction and on the plasma mem-
brane. The secondary granule fraction also contains the
so-called tertiary granules or gelatinase granules [25]. The
association of MRP8/14 with neutrophil plasma mem-
branes and primary granules was similar to the associa-
tion of MRP8/14 with macrophage plasma membranes
[2,27]. Thus while in macrophages MRP8/14 is found pri-
marily in cytosol, its distribution of depends on the acti-
vation state of the macrophages. In resting macrophages
MPR8/14 is in the cytosol, but when macrophages are
stimulated, it translocates to the cell membrane and
cytoskeleton. The association of MRP8/14 with macro-
phage membranes is calcium dependent [27]. We found
that MRP8 and MRP14 had a loose calcium-dependent
adherence to neutrophil primary granules and plasma
membranes and they were removed from these mem-
branes by washing with EGTA in a high ionic strength
Subcellular distribution of proteins recognized by antibody  AHN-17 Figure 3
Subcellular distribution of proteins recognized by antibody 
AHN-17. Primary granules, secondary granules, plasma mem-
branes, and cytosol were isolated from the neutrophils by 
nitrogen cavitation and differential centrifugation and were 
suspended in extraction buffer. The antigens recognized by 
antibody AHN-17 were isolated from each fraction by affinity 
chromatography with ANH-17 and were analyzed by SDS-
PAGE in a 10% gel under non-reducing (lanes A-D) and 
reducing conditions (lanes E-H). The amount of antigen 
applied to each lane was adjusted to represent the same per-
centage of starting material. Primary granules are shown in 
lanes A and E, secondary granules in lanes B and F, plasma 
membranes in lanes C and G, and cytosol in lanes D and H. 
Gels were stained with coomassie blue.Journal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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buffer. Lemarchand and coworkers also found that MRP8/
14 was associated with neutrophil plasma membranes via
a calcium-dependent mechanism [28].
The association for MRP8/14 with secondary granules was
different than its association with plasma membranes and
primary granules; MRP8/14 was within the contents of the
secondary granules. It could not be removed from the sec-
ondary granules by EGTA washes and when secondary
granule membranes were separated from their soluble
contents, almost all of the MRP8/14 was found to be
present in the soluble contents of the secondary granules.
We found that MRP8/14 is released within seconds from
secondary and or tertiary granules by stimulated neu-
trophils. MRP8/14 was detected in the supernatant of cells
incubated with buffer possibly due to the loss of MRP8/14
associated with plasma membranes. However, following
the incubation of cells with stimulants known to cause the
release of secondary granules and tertiary granules, MRP8/
14 was released from neutrophils. The subcellular frac-
tionation technique used in this study separated neu-
trophils into cytosol, primary granule, secondary granule
and plasma membrane fractions. The secondary granule
fraction also likely contained tertiary granules [25,29,30],
and MRP8 and MRP14 may also be present in tertiary
granules.
It is not certain why other studies did not detect MRP8 and
MRP14 in neutrophil granules [3,10,17]. The structure of
MRP8 and MRP14 in the cytosol may differ from the
structure of granule MRP8 and MRP14, and it is possible
that some antibodies may recognize the cytosol proteins
but not the granule proteins. Alternatively, the state of
neutrophil activation may have differed between the stud-
ies. While MRP8/14 is associated with plasma mem-
Analysis of neutrophil cytosol, plasma membranes, primary granules, and secondary granules by immunoblotting with mono- clonal antibody 15H9 Figure 4
Analysis of neutrophil cytosol, plasma membranes, primary granules, and secondary granules by immunoblotting with mono-
clonal antibody 15H9. Neutrophil plasma membranes, cytosol, primary granules and secondary granules were prepared by 
nitrogen cavitation and differential centrifugation. Primary and secondary granules were disrupted and the membrane and con-
tents were separated as described in the text. Cytosol (lane A), primary granule membranes (lane B), secondary granule mem-
branes (lane C), plasma membranes (lane D), primary granules contents (lane E), and secondary granule contents (lane F) were 
analyzed by SDS-PAGE in a 13% gel under reducing conditions and were immunoblotted with antibody 15H9 (left panel) or 
NMS (right panel). Five micrograms of protein was added to each lane except for lane D in which 2 micrograms of protein was 
analyzed.Journal of Translational Medicine 2005, 3:36 http://www.translational-medicine.com/content/3/1/36
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branes, they are not integral membrane proteins. Neither
has a membrane-anchor sequence [4]. When neutrophils
are activated, the quantities of both MRP8 and MRP14
associated with plasma membranes increases [28].
The presence of MRP8/14 in neutrophil secondary gran-
ules suggests that neutophils contribute to the deposition
of MRP8/MRP14 on endothelium. Since adherent neu-
trophils release secondary granules, it is likely that at sites
of acute inflammation when neutrophils bind to
endothelial cells they degranulate and release MRP8/14
which stimulates endothelium and induces thrombotic
and proimflamatory changes. This suggests that MRP8/14
has an important role in neutrophil mediated
inflammation.
In summary, MRP8 and MRP14 are located not only in
neutrophil cytosol but also in secondary and/or tertiary
granules. The release of secondary granules and MPR8/14
by activated neutrophils suggests that MRP8/14 plays an
important role in neutrophil induced inflammation.
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